Nina Bauer PhD, MBA

Nina Bauer is the Commercial Development Lead of Lonza’s autologous cell therapy business. She is in charge of establishing novel manufacturing technologies to remove bottlenecks and enable commercial services for patient-scale therapies. Prior to joining Lonza, Nina held business development roles at the Cell Therapy Catapult (London), and the University of Edinburgh, and worked as Life Science Consultant for regenerative medicine businesses. She holds a PhD in Neuroscience from the University of Oldenburg (GER), an MBA from the University of Edinburgh (UK), and conducted post-doctoral research at the Weizman Institute (ISR), Salk Institute (USA), and the University of Edinburgh (UK).